Table of Contents Author Guidelines Submit a Manuscript
Psychiatry Journal
Volume 2016, Article ID 5480391, 4 pages
http://dx.doi.org/10.1155/2016/5480391
Research Article

Cognitive Function before and during Treatment with Selective Serotonin Reuptake Inhibitors in Patients with Depression or Obsessive-Compulsive Disorder

1Education Development Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz 61357-15794, Iran
3Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Received 16 April 2016; Accepted 21 July 2016

Academic Editor: Lenin Pavón

Copyright © 2016 Mehdi Sayyah et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Abramowitz, “Treatment of obsessive-compulsive disorder in patients who have comorbid major depression,” Journal of Clinical Psychology, vol. 60, no. 11, pp. 1133–1141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. A. Marken and J. S. Munro, “Selecting a selective serotonin reuptake inhibitor: clinically important distinguishing features,” The Primary Care Companion for CNS Disorders, vol. 2, no. 6, pp. 205–210, 2000. View at Google Scholar
  3. J. Price, V. Cole, and G. M. Goodwin, “Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study,” British Journal of Psychiatry, vol. 195, no. 3, pp. 211–217, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Biringer, A. Rongve, and A. Lund, “A review of modern antidepressants' effects on neurocognitive function,” Current Psychiatry Reviews, vol. 5, no. 3, pp. 164–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Gallassi, R. Di Sarro, A. Morreale, and M. Amore, “Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy,” Journal of Affective Disorders, vol. 91, no. 2-3, pp. 243–250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Trivedi, E. H. Lin, and W. J. Katon, “Consensus recommendations for improving adherence, self-management, and outcomes in patients withdepression,” CNS Spectrums, vol. 12, no. 8, supplement 13, pp. 1–27, 2007. View at Google Scholar
  7. A. M. Nye, V. B. Clinard, and C. L. Barnes, “Medication nonadherence secondary to drug-induced memory loss,” Consultant Pharmacist, vol. 25, no. 2, pp. 117–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. C.-Y. Cheng, B. Y.-J. Lin, K.-H. Chang, K.-H. Shu, and M.-J. Wu, “Awareness of memory impairment increases the adherence to immunosuppressants in kidney transplant recipients,” Transplantation Proceedings, vol. 44, no. 3, pp. 746–748, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Wojtyńska and D. Szcześniak, “DemTect®—effective to asses mci and dementia—validation study of the polish language version,” Aging and Mental Health, vol. 20, no. 5, pp. 510–516, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. L. A. Cummings-Vaughn, N. N. Chavakula, T. K. Malmstrom, N. Tumosa, J. E. Morley, and D. M. Cruz-Oliver, “Veterans affairs saint louis university mental status examination compared with the montreal cognitive assessment and the short test of mental status,” Journal of the American Geriatrics Society, vol. 62, no. 7, pp. 1341–1346, 2014. View at Publisher · View at Google Scholar
  11. A. J. Mitchell, “A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment,” Journal of Psychiatric Research, vol. 43, no. 4, pp. 411–431, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Jacova, A. Kertesz, M. Blair, J. D. Fisk, and H. H. Feldman, “Neuropsychological testing and assessment for dementia,” Alzheimer's and Dementia, vol. 3, no. 4, pp. 299–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Seyedian, M. Falah, M. Norouzian, S. Nejat, A. Delavar, and H. Ghasemzadeh, “Validity of the Farsi version of mini-mental state examination,” Journal of Medical Council of Islamic Republic of Iran, vol. 24, no. 4, pp. 408–414, 2008. View at Google Scholar
  14. M. Noroozian and L. Kouti, “Severity of Parkinson's disease and memory function: correlation and influencing factors,” The Journal of Nutrition Health and Aging, vol. 17, supplement 1, pp. S594–S595, 2013. View at Google Scholar
  15. K. R. Chapman, H. Bing-Canar, M. L. Alosco et al., “Mini mental state examination and logical memory scores for entry into Alzheimer's disease trials,” Alzheimer's Research and Therapy, vol. 8, article 9, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. M. F. Folstein, S. E. Folstein, and P. R. McHugh, “‘Mini-mental state’: a practical method for grading the cognitive state of patients for the clinician,” Journal of Psychiatric Research, vol. 12, no. 3, pp. 189–198, 1975. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Levkovitz, R. Caftori, A. Avital, and G. Richter-Levin, “The SSRIs drug Fluoxetine, but not the noradrenergic tricyclic drug Desipramine, improves memory performance during acute major depression,” Brain Research Bulletin, vol. 58, no. 4, pp. 345–350, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. M. E. Culang-Reinlieb, J. R. Sneed, J. G. Keilp, and S. P. Roose, “Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline,” International Journal of Geriatric Psychiatry, vol. 27, no. 8, pp. 777–784, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Herrera-Guzmán, J. E. Herrera-Abarca, E. Gudayol-Ferré et al., “Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder,” Psychiatry Research, vol. 177, no. 3, pp. 323–329, 2010. View at Google Scholar
  20. M. Deuschle, A. Kniest, H. Niemann et al., “Impaired declarative memory in depressed patients is slow to recover: clinical experience,” Pharmacopsychiatry, vol. 37, no. 4, pp. 147–151, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Popovic, E. Vieta, M. Fornaro, and G. Perugi, “Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants,” Journal of Affective Disorders, vol. 173, pp. 211–215, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. E. J. K. Wadsworth, S. C. Moss, S. A. Simpson, and A. P. Smith, “SSRIs and cognitive performance in a working sample,” Human Psychopharmacology, vol. 20, no. 8, pp. 561–572, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. J. D. Joss, R. M. Burton, and C. A. Keller, “Memory loss in a patient treated with fluoxetine,” Annals of Pharmacotherapy, vol. 37, no. 12, pp. 1800–1803, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Hall, R. D. Barrera, and M. Randon, “Reversible memory loss following treatment with fluoxetine: a case study,” Behavioral Interventions, vol. 15, no. 3, pp. 217–224, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Serretti, R. Calati, A. Goracci, M. Di Simplicio, P. Castrogiovanni, and D. De Ronchi, “Antidepressants in healthy subjects: what are the psychotropic/psychological effects?” European Neuropsychopharmacology, vol. 20, no. 7, pp. 433–453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Meneses, “5-HT systems: emergent targets for memory formation and memory alterations,” Reviews in the Neurosciences, vol. 24, no. 6, pp. 629–664, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Meneses, G. Perez-Garcia, T. Ponce-Lopez, R. Tellez, and C. Castillo, “Serotonin transporter and memory,” Neuropharmacology, vol. 61, no. 3, pp. 355–363, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Benmansour, M. Cecchi, D. A. Morilak et al., “Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level,” The Journal of Neuroscience, vol. 19, no. 23, pp. 10494–10501, 1999. View at Google Scholar · View at Scopus
  29. M. M. Herzallah, A. A. Moustafa, J. Y. Natsheh et al., “Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder,” Journal of Affective Disorders, vol. 151, no. 2, pp. 484–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. V. Rashedi, M. Rezaei, and M. Gharib, “Prevalence of cognitive impairment in community-dwelling older adults,” Basic and Clinical Neuroscience, vol. 5, no. 1, pp. 28–30, 2014. View at Google Scholar · View at Scopus